AHA President Rick Pollack to retire by end of 2026 / Fierce
fiercehealthcare - Longtime American Hospital Association President Rick Pollack will retire by the end of 2026, the organization announced on Wednesday.
#healthcare #publichealth #governmentpolicy
Wednesday, December 10, 2025, 6:23 pm / permalink 16812 / 3 stories in 3 months
Novel Endocrine Therapy Giredestrant Improves Disease-free Survival Over Standard of Care for Patients With Early-stage Breast Cancer in Phase III lidERA Trial / American Association for Cancer Research
Kathleen Medora / aacr - SAN ANTONIO – The investigational, oral selective estrogen receptor degrader (SERD) giredestrant given as an adjuvant therapy showed significant improvement in invasive disease-free survival (iDFS) compared with the current standard-of-care endocrine ther…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment
Wednesday, December 10, 2025, 11:22 am / permalink 16789 / 15 stories in 3 months
ACA approval hits new high as subsidies set to expire: 7 things to know / Beckers
Alan Condon / beckershospitalreview - Approval of the ACA recently climbed to a new high of 57% — driven largely by a surge in support among independents — even as pandemic‑era enhanced subsidies are set to expire Dec. 31 unless Congress acts, according to a survey published Dec. 8 by the Wes…
#healthcare #drugpricing #publichealth #governmentpolicy
Monday, December 8, 2025, 12:22 pm / permalink 16702 / 21 stories in 3 months
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds / ABC News
go - A new study suggests a single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer
#healthcare #publichealth #vaccinesafety
Monday, December 8, 2025, 12:21 am / permalink 16678 / 3 stories in 3 months
CVS Health agrees to pay $37.8M to settle fraud allegations over insulin pens / Fierce
fiercehealthcare - CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and improperly billed federal healthcare programs for those prescriptions.
#healthcare #pharmaceuticals #drugpricing #publichealth #corporatetakeover
Monday, December 8, 2025, 12:21 am / permalink 16679 / 2 stories in 3 months
Will All Newborns Still Receive Hepatitis B Shots? A Committee’s Vote Will Tell. / NYT
Apoorva Mandavilli / nytimes - The federal vaccine panel appointed by Health Secretary Robert F. Kennedy Jr. is likely to decide on Thursday that the shots should be delayed for infants whose mothers test negative for the virus.
#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety
Sunday, December 7, 2025, 10:22 am / permalink 16672 / 6 stories in 3 months
California Discourages Wild Mushroom Foraging After Fatal Outbreak / NYT
Hannah Ziegler / nytimes - Officials said one person was killed and 20 others were poisoned after eating death cap mushrooms, which look and taste like safe mushrooms but can cause liver failure.
#healthcare #publichealth #governmentpolicy
Saturday, December 6, 2025, 8:21 pm / permalink 16668 / 3 stories in 3 months
Startup Protego Bio Lands $130M for First-in-Class Drug’s Pivotal Test in Rare Plasma Disorder / MedCity
Frank Vinluan / medcitynews - Protego Biopharma’s lead program is a potential treatment for the rare disease light chain amyloidosis. The startup says the novel mechanism of its oral small molecule should have better outcomes than antibodies from AstraZeneca and Prothena that failed t…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment
Saturday, December 6, 2025, 10:21 am / permalink 16661 / 2 stories in 3 months
Rabi Hanna: Excited to Participate in ASH-a-palooza at ASH25 / OncoDaily
oncodaily - Rabi Hanna, Chairman at Department of Pediatric Hematology-Oncology and BMT at Cleveland Clinic, shared a post on X: “Excited to participate in ASH-a-palooza at ASH25 BLOOD BUDDIES. Designed for undergraduates, medical […]
- ASH25 Conference Buzz (8)
- ASH25 Research Highlights (3)
- Other (1)
- Pharma Innovations at ASH25 (2)
- All Other Stories
ASH25 Conference Buzz
ASH25 Research Highlights
Other
Pharma Innovations at ASH25
All Other Stories
Saturday, December 6, 2025, 7:21 am / permalink 16654 / 27 stories in 3 months
ACIP drops universal hepatitis B birth dose recommendation / Endpoints
Max Bayer / endpoints - A panel of CDC vaccine advisors has stopped recommending that all children receive the hepatitis B vaccine at birth, overruling scientific consensus and public health officials who pleaded that there was no grounded rationale for ...
#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety
Friday, December 5, 2025, 11:22 am / permalink 16612 / 14 stories in 3 months
A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes / Fierce
fiercehealthcare - Drastic overhauls of U.S. vaccine regulations proposed by top FDA official Vinay Prasad, M.D., have drawn harsh pushback from 12 former commissioners of the agency.
#healthcare #publichealth #governmentpolicy #biotech #drugdevelopment #fda #vaccinesafety
Thursday, December 4, 2025, 10:23 am / permalink 16565 / 10 stories in 3 months
UK and US agree zero-tariff deal on pharmaceuticals / ABC News
go - Officials say the U.K. has sealed a deal securing a 0% tariff rate for all U.K. medicines exported to the U.S. for at least 3 years, in return for the U.K. spending more on new medicines
#healthcare #pharmaceuticals #drugpricing #governmentpolicy
Monday, December 1, 2025, 1:23 pm / permalink 16444 / 6 stories in 3 months
FDA approves all ages gene therapy for spinal condition / Beckers
Ella Jeffries / beckershospitalreview - The FDA approved Novartis’ Itvisma (onasemnogene abeparvovec-brve), the company’s first and only gene replacement therapy for spinal muscular atrophy in children 2 and older, as well as for teens and adults. The therapy is designed to address the genetic …
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda
Monday, December 1, 2025, 4:21 am / permalink 16428 / 2 stories in 3 months
Novo submits high-dose Wegovy for FDA approval using voucher / Endpoints
Max Bayer / endpoints - Novo Nordisk submitted a higher dose of its obesity drug Wegovy for FDA approval and is using a recently-won voucher to expedite the review. The company said Wednesday that it submitted ...
#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #publichealth #biotech #drugdevelopment #fda
Saturday, November 29, 2025, 5:21 pm / permalink 16400 / 2 stories in 3 months
CASSANDRA-PACT-21 Trial Update: Preoperative PAXG vs mFOLFIRINOX in Resectable and Borderline Resectable PDAC / OncoDaily
oncodaily - The landscape of early-stage pancreatic ductal adenocarcinoma (PDAC) continues to evolve as clinicians move from surgery-first strategies toward perioperative treatment. Neoadjuvant and perioperative approaches have shown growing promise, yet no […]
#healthcare #pharmaceuticals #publichealth #drugdevelopment
Saturday, November 29, 2025, 9:21 am / permalink 16387 / 5 stories in 3 months
Tracking with care: The ethics of using location tracking technology with people living with dementia / Medical Express
medicalxpress - Imagine you're 83 years old, living with dementia in a long-term care home. Lately, your caregivers keep asking you to wear a bracelet on your wrist 24/7. They say it's for your safety, so they can locate you quickly when needed.
Saturday, November 29, 2025, 5:21 am / permalink 16384 / 2 stories in 3 months
Novo Nordisk GLP-1 fails to slow Alzheimer’s in trials / Beckers
Ella Jeffries / beckershospitalreview - Novo Nordisk’s GLP-1 drug semaglutide did not demonstrate a statistically significant effect in slowing progression of Alzheimer’s disease in two late-stage clinical trials. According to a Nov. 24 news release from the company, two double-blinded, placebo…
#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #publichealth #biotech #drugdevelopment
Tuesday, November 25, 2025, 10:21 am / permalink 16294 / 5 stories in 3 months
FDA Approves Pembrolizumab + Enfortumab Vedotin-ejfv for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer / OncoDaily
oncodaily - What Does FDA Approval Mean? The U.S. Food and Drug Administration (FDA) evaluates new cancer therapies to determine whether they are safe and effective for clinical use. Approval is based […]
#healthcare #pharmaceuticals #publichealth #drugdevelopment #fda
Monday, November 24, 2025, 10:23 am / permalink 16257 / 2 stories in 3 months
M. Tezer Kutluk: 2025 Update of World Cancer Declaration with UICC Board / OncoDaily
oncodaily - M. Tezer Kutluk, Professor of Pediatrics and Pediatric Oncologists, Chair of the Scientific Board at Medicana Health Group, shared a post on LinkedIn: “Dear friends, Between 18–20 November 2025 in Melbourne, […]
- Geriatric Oncology Updates (5)
- Global Cancer Leadership & Policy (9)
- Innovative Cancer Treatment & Research (16)
- Other Cancer & Related Topics (17)
Geriatric Oncology Updates
Global Cancer Leadership & Policy
Innovative Cancer Treatment & Research
Other Cancer & Related Topics
Monday, November 24, 2025, 4:21 am / permalink 16241 / 47 stories in 3 months
New nasal nanodrops wipe out brain tumors in mice / Science Daily Cancer
sciencedaily - A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune pathway using gold-core spherical nucleic acids, researchers were able to reach the brain without invasive surgery. When paired with dru…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment
Saturday, November 22, 2025, 1:21 pm / permalink 16217 / 3 stories in 3 months